Newsmeme!
Discover News you didn't know existed
The notices represent another step towards full patent protection for the canola proteins that Burcon has been developing since 1999. A notice of allowance is written notification that a patent application has cleared internal review and is nearing issuance.
Sequenom, Inc. announced the launch of the SensiGene Fetal RHD Genotyping test by Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM). This is the company's first laboratory developed test powered by its SEQureDx technology.
Eight people who were exposed to a dog with rabies in rural Ellinwood in recent days are receiving preventative medical treatment. Barton County Health Department Director Lily Akings confirmed that a rural family’s dog contracted rabies, reportedly after being in a fight with a skunk.
The Volusia County Health Department issued a 60-day rabies alert Thursday for five miles of the beachside from unincorporated Wilbur-by-the-Sea to the southern limit of Ponce Inlet after three unprovoked attacks on humans by raccoons.
Sequenom, Inc. today announced the launch of the SensiGene™ Fetal RHD Genotyping test by Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM).
NEW YORK (GenomeWeb News) – Shares of Sequenom were up around 7 percent at $4.36 in mid-afternoon trade on the Nasdaq, after the firm announced the launch of its SensiGene Fetal RHD Genotyping test.
LACHEN, Switzerland and HOBOKEN, N.J., Feb.
The Volusia County Health Department has issued a rabies alert following three unprovoked attacks on humans by raccoons last month.
Vancouver, BC, February 4, 2010--(T-Net)--Burcon NutraScience Corporation (TSX - BU) announced today that it has received a notice of allowance from the United States Patent and Trademark Office for a patent application covering processes for the production of canola protein isolates whereby the resulting isolates are separated into their native underlying protein fractions.
Octapharma USA will accept applications until March 31 for the Octapharma 25th Anniversary Grants Program, which supports clinical or pre-clinical research focused on human protein therapies in coagulation disorders, immunotherapy, intensive care and emergency medicine.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |